1. Home
  2. CCOI vs NNNN Comparison

CCOI vs NNNN Comparison

Compare CCOI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCOI
  • NNNN
  • Stock Information
  • Founded
  • CCOI 1999
  • NNNN 2021
  • Country
  • CCOI United States
  • NNNN Germany
  • Employees
  • CCOI N/A
  • NNNN N/A
  • Industry
  • CCOI Telecommunications Equipment
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CCOI Consumer Discretionary
  • NNNN Health Care
  • Exchange
  • CCOI Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • CCOI 2.4B
  • NNNN 2.2B
  • IPO Year
  • CCOI N/A
  • NNNN 2025
  • Fundamental
  • Price
  • CCOI $37.34
  • NNNN $42.30
  • Analyst Decision
  • CCOI Buy
  • NNNN
  • Analyst Count
  • CCOI 6
  • NNNN 0
  • Target Price
  • CCOI $49.17
  • NNNN N/A
  • AVG Volume (30 Days)
  • CCOI 1.6M
  • NNNN 57.1K
  • Earning Date
  • CCOI 11-06-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • CCOI 10.87%
  • NNNN N/A
  • EPS Growth
  • CCOI N/A
  • NNNN N/A
  • EPS
  • CCOI N/A
  • NNNN 0.06
  • Revenue
  • CCOI $921,889,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • CCOI $5.37
  • NNNN N/A
  • Revenue Next Year
  • CCOI $6.45
  • NNNN N/A
  • P/E Ratio
  • CCOI N/A
  • NNNN $795.01
  • Revenue Growth
  • CCOI N/A
  • NNNN 21.95
  • 52 Week Low
  • CCOI $29.62
  • NNNN $5.18
  • 52 Week High
  • CCOI $86.76
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • CCOI 46.69
  • NNNN N/A
  • Support Level
  • CCOI $35.05
  • NNNN N/A
  • Resistance Level
  • CCOI $37.54
  • NNNN N/A
  • Average True Range (ATR)
  • CCOI 1.50
  • NNNN 0.00
  • MACD
  • CCOI 0.33
  • NNNN 0.00
  • Stochastic Oscillator
  • CCOI 72.13
  • NNNN 0.00

About CCOI Cogent Communications Holdings Inc.

Cogent carries over one fifth of the world's internet traffic over its network and is a broadband provider for businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: